Beta blockers and fracture risk in osteoporosis
Part of Bones, joints & muscles, Heart & circulation clinical trials.
This study tests whether using beta blocker blood pressure medicines affects the risk of fractures in people with osteoporosis. It may help doctors understand which medication choices lower fracture risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 50 or older and have osteoporosis
- You can have high blood pressure or normal blood pressure
- Your bone density test shows low bone strength (osteoporosis range)
- You are NOT currently taking certain osteoporosis-improving drugs like ACE inhibitors, ARBs, or statins
- You are NOT currently taking certain osteoporosis-worsening drugs like corticosteroids, anti-seizure medicines, or proton pump inhibitors
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.
This trial studies whether doing a structured bone-focused exercise program, taking alendronate (a medication that slows bone loss), and making a calorie-reducing diet can improve bone strength in people with low bone density. It also compares different combinations to see what helps most and is safest for you.
This study looks at whether starting a new blood pressure medication raises the risk of breaking a bone soon after. It uses health records to compare people who just started treatment with those who haven't started yet.
This study looks at how delays in starting bone-strengthening medications affect people with osteoporosis and previous fragility fractures (breaks from minor falls or without obvious injury). The goal is to understand the real-world impact of when treatment begins.
This study tests whether a medicine called alendronate can help prevent pelvic bone fractures in women with cervical cancer who are getting chemo-radiation. If you qualify, you may receive the study drug to strengthen your bones during treatment.
This trial tests if beta-blocker medication improves blood flow and reduces resistance in the tiny blood vessels of the heart in people who have chest pain but no major blockages in their arteries.
Hear when a new Beta Blocker Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.